GlassScriptPhysician profile
Carmen Woolums
NPI 1992756829
$9,266.05
in general payments reported to CMS, 2019-2025
43 companies · $2,045 in 2025
The $2,045 reported for 2025 was more than what 93% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $853 · 2022: $1,386 · 2023: $2,499 · 2024: $2,482 · 2025: $2,045.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,027.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,026.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,509.52 | 2021-2025 | |
| Glaxosmithkline, LLC. | $971.06 | 2021-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Lilly USA, LLC | $862.00 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $806.42 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $739.05 | 2021-2025 | Farxiga, Airsupra, Breztri |
| Pfizer INC. | $655.87 | 2022-2025 | |
| Otsuka America Pharmaceutical, INC. | $439.75 | 2021-2025 | Rexulti |
| Boehringer Ingelheim Pharmaceuticals, INC. | $296.13 | 2021-2024 | Jardiance, Synjardy, Tradjenta |
| Exact Sciences Corporation | $266.21 | 2023-2025 | Cologuard Collection Kit |
| Amgen INC. | $251.48 | 2021-2025 | Otezla, Repatha, Otezla |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $247.27 | 2023-2025 | Xifaxan |
| Sanofi-Aventis U.S. LLC | $212.83 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $211.37 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $185.61 | 2021-2025 | |
| Abbott Laboratories | $177.46 | 2021-2025 | Freestyle Libre 3 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carmen Woolums listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.